MiniMed Group, Inc. Common Stock
MMED
株式のランク
#3404
MiniMed Group, Inc. specializes in designing, producing, and distributing a... MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
株価
$17.87
最終同期: 2026-10-21
時価総額
$5.03B
変化（1日）
2.14%
変化（1年）
-
国
US
取引 MiniMed Group, Inc. Common Stock (MMED)
カテゴリー
Healthcare
MiniMed Group, Inc. Common Stock（MMED）の収益
Oct 2026 時点の収益 TTM: 0
MiniMed Group, Inc. Common Stock の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
MiniMed Group, Inc. Common Stock の収益履歴（2023 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2025 | $2.72B | 9.96% |
| 2024 | $2.47B | 9.98% |
| 2023 | $2.25B | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $2.58B | - |
US
|
|
| - | - |
US
|
|
| - | - |
US
|
|
| 0.00 | - |
IL
|
|
| $249.73M | - |
US
|
